Despite decades of genomic sequencing and the rapid rise of artificial intelligence, the human genome remains one of the most resistant puzzles to computational modeling. Once celebrated as a static genetic blueprint, modern research reveals the genome as a highly dynamic, three-dimensional regulatory network. This fundamental shift is exposing inherent limitations in AI-driven genomic foundation models like Google DeepMind’s AlphaGenome, Evo 2, and Genos, which rely on linear sequence data to predict biological outcomes. The traditional view treated the genome as a straightforward code: DNA sequences are transcribed into mRNA, which ribosomes translate into proteins. While this central dogma holds, only roughly two percent of human DNA actually encodes proteins. The remaining vast noncoding regions govern gene regulation through an intricate web of mechanisms. Transcription factors do not act as simple on-off switches as seen in bacteria; instead, they operate on combinatorial logic, integrating multiple contextual signals. These factors bind to enhancers, which can reside millions of nucleotides away from their target genes. To bridge this distance, the genome relies on chromatin looping mediated by cohesin proteins, folding DNA into topologically associating domains that bring distant regulatory elements into proximity. Compounding this spatial complexity are epigenetic modifications and RNA-level interventions. Chemical marks on histones dynamically alter chromatin accessibility, effectively acting as contextual annotations rather than fixed instructions. Post-transcriptional processes, including alternative splicing and microRNA silencing, add further layers of decision-making. The result is a self-referential system that continuously adjusts gene expression based on cellular environment, developmental stage, and external stimuli. AI genomic models attempt to bypass this complexity by training on massive datasets to find correlations between DNA sequences and phenotypic traits. Proponents argue that regulatory mechanisms will be implicitly captured within the algorithm’s black box. However, leading genomicists warn this approach is fundamentally incomplete. Wendy Bickmore of the University of Edinburgh notes that current models lack critical data on developmental trajectories, tissue-specific variations, and the full spectrum of regulatory interactions. Adrian Woolfson of Genyro expands this critique, arguing that genetic sequences alone cannot account for the informiome, the dense network of epigenetic, environmental, and microbial factors that dictate biological function. Without integrating these dimensions, AI predictions will remain probabilistic rather than deterministic. The consensus among experts is that the genome cannot be reduced to a computational algorithm. Historical insights from Nobel laureate Barbara McClintock, who described the genome as a highly sensitive organ that monitors and restructures itself in response to stress, now align with contemporary findings. Researchers emphasize that while AI will accelerate pattern recognition and hypothesis generation, it cannot replace mechanistic understanding. Bridging the gap between sequence data and biological reality will require models that explicitly incorporate three-dimensional chromatin architecture, epigenetic states, and environmental context. As the field coalesces around this more holistic framework, the intersection of synthetic biology, advanced AI, and systems genetics will likely define the next era of precision medicine and genomic research.